about
CT-based attenuation correction in I-123-ioflupane SPECTThe relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regressionComparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.Application of in vivo imaging techniques to monitor therapeutic efficiency of PLX4720 in an experimental model of microsatellite instable colorectal cancer.[68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression.Peptide receptor radionuclide therapy with 177Lu-DOTA-octreotate: dosimetry, nephrotoxicity, and the effect of hematological toxicity on survival.Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy.Repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment-refractory auditory hallucinations and major self-mutilation.Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.[18F]fallypride-PET/CT Analysis of the Dopamine D₂/D₃ Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection.External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies.[18F]-florbetaben PET/CT imaging in the Alzheimer's disease mouse model APPswe/PS1dE918F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial InfarctionContinuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input FunctionFirst-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
P50
Q35287222-83543B27-A6DD-4B73-B8B2-A0F137C862C2Q35864927-2C5EEE55-4EDB-4CE0-A7CE-22EDFA22208EQ38826572-131ED6F1-7F7A-41A7-9061-71DB90BEFC5AQ38962393-7C2FD17B-409C-497B-BF2E-870497CCB872Q42378376-C0BDD258-DD22-4EDB-9042-F8D9061184E7Q47099762-1276A636-B4CE-492C-8872-C9C3C19A5AE5Q47190644-EB1A01D1-45C4-4173-9F5E-7A9CE68C52C6Q48309245-61983F5A-1A86-491A-9C1E-6F11E40838F7Q48375142-5102A65F-FC4B-45DD-B12A-B7242C8E1881Q52982270-8A3CE1EB-9658-4C71-8933-20344025ED1EQ53440586-326E3DB5-8828-4FC5-A675-FA287BCD5933Q53695831-2ABDBC04-410E-49B4-BAA3-B517831E6414Q57806413-2D22BBD3-193D-4C27-A1D6-87FAA5B7C5EEQ91966565-AAD2F486-4A12-49B4-B946-4301A3649B05Q92865540-5B743AE4-A26D-470A-835E-A574851EE2BAQ93090504-EF245199-6A20-4872-84A4-A460F552BFB8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jens Kurth
@ast
Jens Kurth
@en
Jens Kurth
@es
Jens Kurth
@nl
Jens Kurth
@sl
type
label
Jens Kurth
@ast
Jens Kurth
@en
Jens Kurth
@es
Jens Kurth
@nl
Jens Kurth
@sl
prefLabel
Jens Kurth
@ast
Jens Kurth
@en
Jens Kurth
@es
Jens Kurth
@nl
Jens Kurth
@sl
P106
P1153
55643361100
P31
P496
0000-0001-6864-4513